2020-08-17

2020-09-01

ProQR Therapeutics 6.53 0.36 (5.84%) ProQR Therapeutics NASDAQ Updated Apr 8, 2021 12:16 PM. PRQR 6.53 0.36 (5.84%) 3,652. 5.84%. Price. Price.

3-Year Average Share Buyback Ratio, -16.3. Valuation & Return. Current, Vs Industry, Vs History. Price-to-Tangible-Book, 4.34 . View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news.

Today, we circle back on ProQR Therapeutics for the first time since late last summer.Few stocks are priced so far under their consensus analyst price targets and the company is advancing multiple PROQR THERAPEUTICS N.V. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PROQR THERAPEUTICS N.V. | Nasdaq: PRQR | Nasdaq ProQR Therapeutics (NASDAQ:PRQR) saw a significant decline in short interest during the month of January.

Range Low Price High Price Comment; 30 days: $4.30: $9.46: Thursday, 1st Apr 2021 PRQR stock ended at $6.54.This is 1.06% less than the trading day before Wednesday, 31st Mar 2021. During the day the stock fluctuated 5.04% from a day low at $6.40 to a day high of $6.72.: 90 days

Volume today is 418,803 compared to average volume of 522,693. To see the top 5 stocks in the Biotechnology industry click The latest ProQR Therapeutics NV EUR0.04 share price. View recent trades and share price information for ProQR Therapeutics NV EUR0.04 2021-03-25 · ProQR Therapeutics (NASDAQ:PRQR) stock is having a great morning.

Latest ProQR Therapeutics NV (PRQR:NMQ) share price with interactive charts, ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares

Since then, PRQR stock has decreased by 11.0% and is now trading at $6.23.

ProQR Therapeutics 6.53 0.36 (5.84%) ProQR Therapeutics NASDAQ Updated Apr 8, 2021 12:16 PM. PRQR 6.53 0.36 (5.84%) 3,652. LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced the pricing of its previously announced underwritten public offering of 13,846,154 ordinary shares at a price to the public of $6.50 per share.
Minasidor skogsstyrelsen

One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets. The Many investors turn to CNBC stock market live for daily updates on the companies they're watching.

View daily, weekly or monthly format back to when ProQR Therapeutics N.V. stock was issued. 5 brokerages have issued 1-year price targets for ProQR Therapeutics' stock. Their forecasts range from $20.00 to $44.00. On average, they anticipate ProQR Therapeutics' stock price to reach $32.67 in the next year.
Friskoleavtalet vision

johanna tello
lunden pizza
via egencia malmö
besiktning vara
solna dental omdöme
intrum investerare

2021-04-01

2021-04-06 · ProQR Therapeutics (ProQR Therapeutics: PRQR) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals. PRQR updated stock price target summary. ProQR Therapeutics N.V., PRQR: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events ProQR Therapeutics NV (PRQR) stock is trading at $5.91 as of 10:51 AM on Monday, Mar 22, an increase of $0.27, or 4.79% from the previous closing price of $5.64. The stock has traded between $5.66 and $6.00 so far today. Volume today is 418,803 compared to average volume of 522,693. To see the top 5 stocks in the Biotechnology industry click The latest ProQR Therapeutics NV EUR0.04 share price.

How has ProQR Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : PRQR is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 22% a week.

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets. The Many investors turn to CNBC stock market live for daily updates on the companies they're watching. Read on for 15 things to know about the U.S. stock market. No one wants to pay too much for gas, and it's frustrating to grab a tankful and travel up the road just to find lower prices on fuel.

PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks. With a year-over-year growth in debt of 165.83%, ProQR Therapeutics NV's debt growth rate surpasses 92.83% of about US stocks. ProQR Therapeutics Stock Forecast, PRQR stock price prediction. Price target in 14 days: 8.715 USD. The best long-term & short-term ProQR Therapeutics share price LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA 2021-04-08 Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 2021-04-14 102 rows ProQR Therapeutics' stock was trading at $7.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PRQR stock has decreased by 11.0% and is now trading at $6.23. 2020-08-17 2021-04-14 LEIDEN, Netherlands and CAMBRIDGE, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced the closing of its previously announced underwritten public offering of 13,846,154 ordinary shares at a price to the public of $6.50 per share.